Patch testing a patient with allergic contact hand dermatitis who is taking infliximab.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18468722.
- Also identified by DOI 10.1016/j.jaad.2008.02.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the case of a patient who developed allergic contact hand dermatitis while receiving infliximab infusions for psoriasis and psoriatic arthritis. Patch testing showed multiple positive allergens. To our knowledge, this is the first case report of successful patch testing in a patient receiving tumor necrosis factor-alpha (TNF-alpha) blockade therapy. TNF-alpha blockers do not necessarily suppress allergic contact hypersensitivity and are not an absolute contraindication to patch testing.
Medical subject headings
- Antibodies, Monoclonal
- Dermatitis, Allergic Contact
- Hand Dermatoses
- Occupational Diseases